Glenmark, Strides Pharma, Cipla recall products in the US due to manufacturing issues

The Drug Suppliers for Glenmark, Strides Pharma and Cipla are recalling products in the Globally vast market (U.S) as there was production issues. As the per the Survey done by US Food and Drug Administration, they submitted a report stating that Glenmark Pharmaceuticals Inc based on New Jersey i...

Glenmark and Aurobindo Pharma to recall products from the US markets

Highlights

•  Aurobindo and Glenmark Pharmaceuticals recall various drugs from the US market
• Various products have been recalled according to enforcement report by USFDA

 Aurobindo Pharma and Glenmark Pharmaceuticals hav...

SENSEX JUMPS 250 POINTS, NIFTY OVER 10,300

Highlights

• The S&P BSE Sensex is trading at 34,037.81 points, while the Nifty50 index is at 10,303.35 levels

• Top Sensex gainers in the early morning session were Bajaj Finance and Bajaj Finserve that showcased growth of 5 percent respectively, followed by Baj...

KNOW MORE ABOUT “LIFE-SAVER” FAVIPIRAVIR LAUNCHED BY GLENMARK TO TREAT MILD COVID-19 CASES

Highlights:                

• Favipiravir the new antiviral drug is being manufactured by Indian pharma firm Glenmark.
• Favipiravir is effective in mild to moderate cases.

‘FABIFLU’: GLENMARK'S COVID-19 DRUG GETS DGCI APPROVAL

Highlights

• FabiFlu is the first oral Favipiravir-approved medication for the treatment of coronavirus

• Favipiravir was approved in Japan in the year 2014 and shown clinical improvement of up to 88 percent in mild to moderate COVID-19 cases

• Glenmar...

GLENMARK PHARMA RECEIVES USFDA APPROVAL FOR FINGOLIMOD CAPSULES, 0.5 MG

Highlights

• USFDA has given green signal for the production of Fingomolid Capsules that are used in treatment of relapsed form of multiple sclerosis in adults

• At present, Glenmark's portfolio comprises of 164 products authorized for distribution in the US mark...